Navigation Links
Assay Designs(TM), Inc. and the Spinal Muscular Atrophy Foundation Announce Collaboration To Accelerate the Discovery of New Therapeutics for Spinal Muscular Atrophy (SMA)
Date:9/15/2008

ANN ARBOR, Mich., Sept. 15 /PRNewswire/ -- Assay Designs and the Spinal Muscular Atrophy Foundation (SMAF) are very pleased to announce a collaborative agreement for development of reagents and assays for SMN (Survival Motor Neuron) protein to expedite drug discovery and development efforts for spinal muscular atrophy (SMA), the leading genetic cause of mortality in infants and toddlers. "Assay Designs is excited and proud to have been selected by the SMA Foundation, and to help enable better understanding and ultimately improved treatment for this debilitating illness," commented Dan Calvo, President and CEO of Assay Designs. Providing a reliable and widely-available ELISA kit for measuring SMN protein levels will greatly simplify and accelerate the process of assessing the efficacy of potential drugs in clinical trials, which is key to the successful development of new therapeutics for this devastating disease. "We are pleased to bring results from the research sector out for general use in the community," states Loren Eng, president of the SMA Foundation.

SMA is a genetic, motor neuron disease characterized by the wasting of skeletal muscles. Caused by progressive degeneration of nerve cells in the spinal cord, the disease leads to increasing muscular weakness and atrophy. It is estimated that approximately 1 in 6,000 to 1 in 10,000 infants are born annually worldwide with SMA. SMA is often compared to polio because the same spinal cord cells are attacked in each disease. Over time, patients afflicted by this disease continue to lose muscle control and strength, progressively leading to inability to walk, stand, sit up and breathe.

Founded in 2003, the Spinal Muscular Atrophy Foundation is a nonprofit organization dedicated to accelerating progress towards a treatment and cure for spinal muscular atrophy through targeted funding of clinical research and novel drug development efforts. Since its inception, the Foundation has awarded over $50 million in sponsored research agreements. In addition, the Foundation is committed to raising awareness and generating support for increased research efforts in SMA among the leaders of industry and government.

For more than 16 years Assay Designs has supplied the worldwide biomedical research community with immunoanalytical assay solutions for the precise quantification of biomarkers in a variety of sample matrices and species. Since 2005 ADI also provides the full spectrum of Stressgen(R) immunological reagents such as antibodies and proteins, to aid drug discovery and basic research. Assay Designs offers customers one-stop-shop custom development services from antibody and recombinant protein production to the development, validation, and manufacturing of biomarker assays, providing a seamless transition and scale up from pre-clinical to clinical applications.

The collaboration with SMAF is in alignment with Assay Designs' mission to provide researchers with high quality reagents and assays to expedite their efforts in developing new cures and improving the quality of life for patients.

About Assay Designs, Inc.

Based in Ann Arbor, MI, Assay Designs develops and manufactures immunoassay (ELISA) kits, luminescent reagents, antibodies, proteins, and extracts used for life sciences research. The company markets these products under the "Assay Designs" and "Stressgen" brand names. Researchers use the company's products to detect and quantify molecules that are important in inflammation, cell signaling, and cellular stress.


'/>"/>
SOURCE Assay Designs, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Instrumentation Laboratory Receives FDA Clearance to Expand the Intended Use of HemosIL(R) D-Dimer Assay
2. Peakdale Molecular Launches AssayReady4U(TM) in Collaboration With ChemPrintCo LLC
3. FDA Grants Full Approval of PROCLEIX(R) ULTRIO(R) Blood Screening Assay
4. Monogram Biosciences Launches First Resistance Assay for HIV Integrase Inhibitors
5. Spectral announces exclusive distribution agreement in Russia for its EAA(TM) Sepsis Diagnostic Assay
6. Sensitivity Enhancements to Monograms Trofile(TM) Assay Demonstrate Improved Power to Select Patients for CCR5 Antagonist Therapy
7. Monogram Announces Presentation of Clinical Data for the HERmark(TM) Breast Cancer Assay at the 44th ASCO Annual Meeting
8. Gen-Probe Launches in Europe CE-Marked APTIMA(R) HPV Assay for Detection of Human Papillomavirus
9. Pathway Diagnostics Announces Commercial Availability of Second Generation SensiTrop(TM) II Molecular HIV Co-receptor Tropism Assay
10. Assay Designs(TM) Announces Collaboration with Medical University of South Carolina (MUSC)
11. HER1 and HER3 VeraTag(TM) Assays are Now Available for Use in Development and Clinical Evaluation of Cancer Therapeutics
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/27/2017)... Baltimore, MD (PRWEB) , ... April 27, 2017 ... ... analytics solutions provider for digital pathology, today announced their digital pathology technology has ... Using images provided by five medical centers in The Netherlands as part of ...
(Date:4/27/2017)... ... April 27, 2017 , ... During the course of this ... for 1,25-Dihydroxyvitamin D can enhance clinical practice. Participants will learn the medical indications ... , Dr. Gregory Plotnikoff, senior consultant with Minnesota Personalized Medicine, will be the ...
(Date:4/27/2017)... ... 27, 2017 , ... The Council for Agricultural Science and ... Lusk, a consummate communicator who promotes agricultural science and technology in the public ... explains how innovation and growth in agriculture are critical for food security and ...
(Date:4/26/2017)... Myrtle Beach, SC (PRWEB) , ... April 26, ... ... for the mind, has teamed up with NASA to showcase the future of ... NASA’s Space Launch System (SLS) rocket and Orion spacecraft and includes a guest ...
Breaking Biology Technology:
(Date:3/24/2017)... -- Research and Markets has announced the addition of ... - Industry Forecast to 2025" report to their offering. ... The Global Biometric Vehicle ... around 15.1% over the next decade to reach approximately $1,580 million ... estimates and forecasts for all the given segments on global as ...
(Date:3/22/2017)... March 21, 2017 Optimove , ... by retailers such as 1-800-Flowers and AdoreMe, today ... Recommendations and Replenishment. Using Optimove,s machine learning algorithms, ... product and replenishment recommendations to their customers based ... predictions of customer intent drawn from a complex ...
(Date:3/16/2017)... Germany , March 16, 2017 CeBIT 2017 - Against identity ... Continue Reading ... Used combined in one project, multi-biometric solutions provide ... Used ... Systems) ...
Breaking Biology News(10 mins):